Tech entrepreneur Bryan Johnson halts anti-aging drug amid concerns of accelerated aging
4 Articles
4 Articles
Tech entrepreneur Bryan Johnson halts anti-aging drug amid concerns of accelerated aging
Bryan Johnson Experiment with rapamycin leads to unexpected side effects Bryan Johnson, a tech entrepreneur renowned for his ambitious anti-aging endeavors, has ceased using the drug rapamycin after nearly five years of experimentation. Johnson, who invests approximately $2 million annually in efforts to reverse his biological age, revealed that the drug may have inadvertently accelerated aging rather than mitigating it. In a recent YouTube vide…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage